THIAKIS
Thiakis Limited with a focus on developing novel medicines for the treatment of obesity and co-morbidities based on original research conducted by Professor Steve Bloom and his colleagues at Imperial College London.
THIAKIS
Industry:
Biotechnology Life Science
Founded:
2004-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Total Funding:
10 M GBP
Similar Organizations
Guard Therapeutics
Guard Therapeutics develops innovative drugs for the treatment of oxidative stress and acute kidney disease.
Investors List
Advent Venture Partners
Advent Venture Partners investment in Series A - Thiakis
Novo Ventures
Novo Ventures investment in Series A - Thiakis
More informations about "Thiakis"
Thiakis - Crunchbase Company Profile & Funding
Organization. Thiakis . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. About. Thiakis develop novel analogues …See details»
Thiakis - 2025 Company Profile & Team - Tracxn
Thiakis is a series A company based in London (United Kingdom), founded in 2004. It operates as a Limited information available. Thiakis has raised $18.4M in funding. The company has 5 …See details»
Wyeth Buys Thiakis Ltd. - venturecapitaljournal.com
Dec 18, 2008 Wyeth Pharmaceuticals, a unit of Wyeth (NYSE: WYE), has acquired Thiakis Ltd., a UK-based developer of peptide hormones for the treatment of obesity. The deal includes a …See details»
Wyeth Pharmaceuticals Acquires Thiakis Limited
Dec 18, 2008 About Obesity, TKS1225 and Thiakis Based on World Health Organization estimates, globally at least 300 million are obese. Excess body weight is associated with …See details»
Wyeth acquires tiny biotech Thiakis in $150M deal
Dec 18, 2008 Wyeth announced today that its subsidiary, Wyeth Pharmaceuticals, has acquired the U.K.-based biotech company Thiakis Limited for an upfront payment of $30 million. An …See details»
Thiakis 2025 Company Profile: Valuation, Investors, Acquisition
Thiakis is headquartered in London, United Kingdom. What is the size of Thiakis? Thiakis has 3 total employees. What industry is Thiakis in? Thiakis’s primary industry is Biotechnology. Is …See details»
Thiakis | Advent Life Sciences
Dec 18, 2022 Thiakis was acquired by Wyeth in 2008 in a transaction worth up to $150m. Exited Investments. 18 December 2008 in Press Release, Thiakis Wyeth Pharmaceuticals acquires Thiakis in a transaction worth up to £100m. …See details»
Thiakis Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Thiakis Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Thiakis Company Profile | Management and Employees List
Find contact information for Thiakis. Learn about their Business Services, Research & Development market share, competitors, and Thiakis's email format.See details»
Wyeth Acquires Thiakis – Contract Pharma
Wyeth has acquired Thiakis Limited, a privately held biotechnology company based in the United Kingdom. Thiakis’ lead product candidate, TKS1225, is being studied for the treatment of …See details»
Wyeth division buys Thiakis Limited, British biotech company
Dec 18, 2008 Wyeth Pharmaceuticals announced Thursday that it had acquired Thiakis Limited, which is developing TKS1225, a synthetic version of the gastrointestinal peptide …See details»
Thiakis - Products, Competitors, Financials, Employees, …
Wyeth pharmaceuticals aims to bring health care products and resources, medication information and patient education to consumers and health care professionals. Use the CB Insights …See details»
Thiakis Limited - Ownership and Business Overview - Mergr
Dec 18, 2008 Thiakis is the developer of a treatment of severe obesity and comorbidities, including diabetes and heart disease. Company Summary. SECTOR. Life Science. …See details»
Wyeth buys UK biotech Thiakis for $150M
Jan 12, 2009 The firm's lead product candidate, TKS1225, is being studied for the treatment of medical obesity and other co-morbidities. TKS1225 and related compounds are synthetic …See details»
Thiakis Limited Company Profile, Financial and Strategic
Thiakis Limited develops biotechnology products such as TKS1225 which is an analogue of the peptide hormone oxyntomodulin for the treatment of obesity and prevention and amelioration …See details»
THIAKIS LIMITED overview - Find and update company …
More for THIAKIS LIMITED (05148298) Registered office address Pfizer, Ramsgate Road, Sandwich, Kent, CT13 9NJ . Company status Active Company type Private limited Company …See details»
Thiakis Ltd - Company Profile and News - Bloomberg Markets
Company profile page for Thiakis Ltd including stock price, company news, executives, board members, and contact informationSee details»
Wyeth Pharmaceuticals acquires Thiakis - Pharmaceutical Business …
Under the terms of the transaction, Wyeth has acquired Thiakis for approximately $30 million. Additional payments of up to approximately $120 million would be payable upon the …See details»
Wyeth buys UK’s Thiakis and gets hold of obesity compound
Dec 19, 2008 Wyeth is acquiring the privately-held UK biotechnology company Thiakis in a deal that could be worth around $150 million. Wyeth is acquiring the privately-held UK …See details»
Wyeth buys tiny biotech focused on obesity | Reuters
Dec 18, 2008 Wyeth <WYE.N> on Thursday said it had paid $30 million to acquire privately held British biotechnology company Thiakis Ltd and its experimental obesity drug now in early …See details»